Related Experiment Videos

Utility of ERCP in neonatal and infant cholestasis

Lars Aabakken1, Ingegerd Aagenaes, Truls Sanengen

  • 1Department of Medicine, Rikshospitalet University Hospital, Oslo, Norway. larsaa@medisin.uio.no

Insights

Endoscopic retrograde cholangiopancreatography (ERCP) is a safe and feasible diagnostic tool for neonatal cholestasis when other imaging is inconclusive. It aids in diagnosing biliary atresia and other conditions in infants.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Imaging
  • Hepatology

Background:

  • Neonatal and infant jaundice requires early diagnosis.
  • Biliary atresia (BA) and other pancreaticobiliary disorders can be challenging to diagnose noninvasively.
  • Endoscopic retrograde cholangiopancreatography (ERCP) is explored for its utility in these cases.

Purpose of the Study:

  • To evaluate the feasibility and safety of ERCP in neonates and infants with suspected biliary obstruction.
  • To assess ERCP's diagnostic accuracy for conditions like biliary atresia.
  • To determine ERCP's role in the workup of inconclusive jaundice cases.

Main Methods:

  • 23 ERCP procedures were performed in 22 neonates and infants (mean age 2.4 months, mean weight 4.8 kg).
  • A pediatric videoendoscope (7.5 mm outer diameter) was used.
  • ERCP was performed when other imaging modalities were inconclusive for biliary obstruction.

Main Results:

  • ERCP was successful in 20 out of 23 patients.
  • Biliary atresia was correctly suggested in 6 patients, confirmed surgically.
  • ERCP provided detailed visualization for treatment planning in choledochal cysts and perforation cases.

Conclusions:

  • ERCP is a feasible and safe procedure for diagnosing neonatal cholestasis when other imaging fails.
  • ERCP remains valuable in the multidisciplinary approach to diagnosing infant jaundice, even with advanced imaging like MRCP.
Abstract